archive /

AstraZeneca's New Cancer Regimen Cuts Bladder Cancer Death Risk by 42 Per Cent

2026-10-25

Pfizer Advances Next-Generation Childhood Pneumonia Vaccine Following Strong Trial Results

2026-10-25

Amgen and AstraZeneca Report Landmark Survival Gains in Lung Cancer Trial

2026-10-24

Johnson & Johnson's Daily Pill Shows Exceptional Promise Against Advanced Prostate Cancer

2026-10-24

Biotech Giant Argenx Halts Major Trial for Autoimmune Drug

2026-10-08

Historic Ten-Cent Drug Slashes Heart Failure Hospitalisations by a Quarter

2026-05-12

Jaguar Health Pursues Expedited FDA Approval for Rare Paediatric Disease Treatment

2026-05-07

Akeso's Chemotherapy-Free Lung Cancer Treatment Drastically Improves Patient Well-Being

2026-03-31

United Therapeutics Poised to Reshape Lung Disease Market Following Strong Trial Results

2026-03-30

Johnson & Johnson Reports Lasting Success for Once-Daily Psoriasis Pill

2026-03-28